Showing results (31-40 of 130) with videos related to
Sort By:
Pageof 13
Molecular Therapy Oncolytics|November 19, 2020
Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell ResponsesSandra S Ring, Michał Królik, Fabienne Hartmann, et al.Therapeutic Advances in Medical Oncology|August 26, 2024
Melanoma-specific survival of patients with uveal melanoma and liver metastases diagnosed between 2005 and 2021Lisa Wiens, Gerd Grözinger, Helmut Dittmann, et al.European Journal of Cancer (Oxford, England : 1990)|November 6, 2021
Cutaneous melanoma attributable to UVR exposure in Denmark and GermanyUlrike Keim, Sara Gandini, Teresa Amaral, et al.Diagnostics (Basel, Switzerland)|August 10, 2024
An Automated Real-Time PCR Assay versus Next-Generation Sequencing in the Detection of BRAF V600 Mutations in Melanoma Tissue SamplesDaniela Lenders, Irina Bonzheim, Matthias Hahn, et al.European Journal of Cancer (Oxford, England : 1990)|June 1, 2021
Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036Claus Garbe, Ulrike Keim, Sara Gandini, et al.Cancer Immunology, Immunotherapy : CII|September 2, 2018
Organ-specific response to nivolumab in patients with non-small cell lung cancer (NSCLC)Sabine Schmid, Stefan Diem, Qiyu Li, et al.Journal for Immunotherapy of Cancer|September 23, 2025
HLA-A*01:01-B*08:01-C*07:01 is linked to early-onset immune checkpoint inhibitor-induced myositis and myocarditisLeonie Müller-Jensen, Lukas Flatz, Omar Hasan Ali, et al.Journal of Virology|May 16, 2014
Evolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitnessRami Sommerstein, Joel Ramos da Palma, Stephan Olschläger, et al.Oncoimmunology|December 22, 2016
Characterization of nivolumab-associated skin reactions in patients with metastatic non-small cell lung cancerOmar Hasan Ali, Stefan Diem, Eva Markert, et al.Oncoimmunology|December 16, 2021
Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancerMaximilian Boesch, Florent Baty, Werner C Albrich, et al.Pageof 13